GlobeNewswire 28/10/2025 NodThera Announces Appointment of Chris Guiffre, J.D., M.B.A., as Chief Financial Officer
GlobeNewswire 28/10/2025 Zag Bio™ Launches with $80 Million Financing to Advance Thymus-targeted Medicines for Autoimmune Dis...
GlobeNewswire 28/10/2025 Regeneron Reports Third Quarter 2025 Financial and Operating Results
GlobeNewswire 28/10/2025 Press release: Sanofi successfully prices USD 3 billion of bond issue
GlobeNewswire 28/10/2025 UPDATE - Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Imp...
GlobeNewswire 27/10/2025 NodThera Announces First Patients Dosed in RESOLVE-2 Clinical Trial Evaluating Oral NT-0796 in Combi...
GlobeNewswire 27/10/2025 Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock
TeleTrader 24/10/2025 Europe closes mixed amid earnings, US inflation
GlobeNewswire 24/10/2025 Evolving Treatment Landscape for Chronic Spontaneous Urticaria Highlights Significant Unmet Needs an...
TeleTrader 24/10/2025 Europe opens mostly higher amid data, earnings
TeleTrader 24/10/2025 Europe set to open mostly higher amid earnings, data
TeleTrader 24/10/2025 Sanofi's Q3 net sales up 7% to €12.43 billion
GlobeNewswire 24/10/2025 Press release: Q3: continued sales and earnings progress
GlobeNewswire 23/10/2025 RECORDATI APPOINTS MIKE MCCLELLAN AS NEW CHIEF FINANCIAL OFFICER
GlobeNewswire 23/10/2025 Sanofi Deepens Partnership with Medidata to Expedite the Development of New Therapies with an Improv...
GlobeNewswire 22/10/2025 Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering
GlobeNewswire 22/10/2025 Nurix Therapeutics Announces $250.0 Million Registered Offering of Common Stock
GlobeNewswire 22/10/2025 Electra Therapeutics Announces $183 Million Series C Financing to Advance First-in-Class SIRP-Target...
GlobeNewswire 22/10/2025 Nurix Initiates DAYBreak™ Pivotal Study of Bexobrutideg in Relapsed or Refractory Chronic Lymphocyti...
GlobeNewswire 22/10/2025 Press Release: Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 anti...
TeleTrader 21/10/2025 Europe mostly higher premarket ahead of earnings
GlobeNewswire 20/10/2025 Press Release: Sanofi’s Tzield accepted for expedited review in the US for stage 3 type 1 diabetes t...
TeleTrader 20/10/2025 EARNINGS PREVIEW: Intel, Tesla, Netflix and more
GlobeNewswire 20/10/2025 Press Release: ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alph...
GlobeNewswire 20/10/2025 Press Release: Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adult...